Gastroesophageal Junction Cancer
📧 Sign up to get email alerts when something new happens for Gastroesophageal Junction Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer [Phase 2]
Phase 2 study of ramucirumab in gastric and GEJ cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial investigating panitumumab with combination chemotherapy and radiation therapy for esophageal or gastroesophageal junction aden…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea
This clinical trial update notes that the HER2 Advanced Gastric Epidemiology study in Korea has completed. The sponsor is Hoffmann-La Roche …
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction [Phase 2]
Phase 2 trial results evaluating irinotecan in combination with cisplatin for patients undergoing surgery for locally advanced gastric or ga…
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach [Phase 2]
A Phase 2 trial evaluating MM-111 in combination with paclitaxel and trastuzumab for HER2-positive distal esophagus, gastroesophageal juncti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction [Phase 2]
A Phase 2 study of MLN0264 in gastric and gastroesophageal junction adenocarcinoma expressing GC-C was terminated. Results were posted in Ma…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial evaluating sunitinib in patients with relapsed or refractory esophageal or gastroesophageal junction cancer; results …
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery [Phase 2]
A Phase 2 clinical trial evaluating cisplatin, irinotecan, and radiation therapy for resectable esophageal cancer or gastroesophageal juncti…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy and cetuximab in metastatic esophageal cancer or gastroesophageal junction cancer has comp…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer [Phase 2]
Phase 2 trial comparing AZD4547 versus paclitaxel in advanced gastric cancer and gastroesophageal junction cancer was terminated, with resul…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: A Clinical Trial of Apatinib Plus Docetaxel in Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma [Phase 1]
Phase 1 clinical trial evaluating the combination of apatinib and docetaxel in locally advanced or metastatic gastric or GEJ adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Treatment of Malignant Strictures in Esophagus and Gastroesophageal Junction With Covered or Partially Covered Stent. [Phase 2]
A Phase 2 clinical trial evaluating covered or partially covered stents for malignant esophageal and gastroesophageal junction strictures ha…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction [Phase 2]
A Phase 2 study evaluating the combination of bortezomib, paclitaxel, and carboplatin in unresectable, metastatic esophageal or gastroesopha…
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer [Phase 3]
A Phase 3 trial of Herceptin with cisplatin and capecitabine in HER2-positive metastatic gastric or gastroesophageal junction cancer was ter…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach [Phase 1, Phase 2]
Phase I/II trial evaluating tivantinib with FOLFOX for advanced solid tumors including metastatic adenocarcinoma of the distal esophagus, ga…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial tested the combination of docetaxel, 5-fluorouracil, and oxaliplatin in patients with gastric cancer or gastroeso…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma
Roche-sponsored clinical trial update on HER-2 status in gastric and gastroesophageal junction cancers; the study is completed and results w…
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: PET/MR-imaging to Differentiate Between Responders and Non-responders Receiving Preoperative Chemotherapy
A completed clinical trial evaluated PET/MR imaging to differentiate responders from non-responders among patients receiving preoperative ch…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Feasibility, Safety and QoL After Merendino Procedure
Completed clinical trial evaluating feasibility, safety, and quality of life after the Merendino procedure for distal esophagus or gastroeso…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas [Phase 2]
Phase 2 trial evaluating cetuximab with radiation therapy for surgically resectable esophageal and gastroesophageal junction carcinomas; res…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer [Phase 1]
A Phase 1 study evaluating pemetrexed in combination with cisplatin and radiation therapy for esophageal and gastroesophageal junction cance…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ [Phase 1]
Phase 1/1b trial of rilotumumab in Japanese patients with advanced solid tumors and advanced or metastatic gastric or GEJ cancer has complet…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial of ramucirumab in Japanese patients with metastatic gastric or gastroesophageal junction cancer has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Docetaxel+Oxali+/-Cetux Met Gastric/GEJ [Phase 2]
Phase 2 trial assessed docetaxel plus oxaliplatin, with or without cetuximab, in metastatic gastric/GEJ adenocarcinoma; results were posted …
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma [Phase 2]
Phase 2 trial assessing preoperative chemotherapy with bevacizumab and PET-guided salvage therapy in locally advanced but resectable gastric…